07 June 2018
Join us at ESHG 2018 – June 16-19 in Milano, Italy – Booth 392
IntegraGen Genomics offers access to the latest innovative technologies in molecular biology enabling you to implement your genomic research projects and also develops partnerships and collaborations with leading academic and industrial researchers.
14 February 2018
IntegraGen and Twist Bioscience Expand Partnership with Distribution Agreement for SIRIUS and MERCURY Genomic Data Analysis Tools
IntegraGen announces a global distribution agreement with Twist Bioscience for IntegraGen’s portfolio of genomic data analysis tools. The agreement includes distribution rights for SIRIUS™, an online Big Data solution that assists researchers to quickly and intuitively analyze exome data for Mendelian and oncology applications, and MERCURY™, an online (…) »
25 January 2018
IntegraGen Partners with Twist Bioscience
IntegraGen today announced the addition of Twist Bioscience Corporation’s Human Core Exome Complete Kit, a streamlined library prep and exome enrichment solution, to its next-generation targeted sequencing product offerings. Under the terms of the agreement Twist Bioscience will provide IntegraGen its Human Core Exome Complete Kit for all target (…) »
18 January 2018
IntegraGen Launches SIRIUS™ and MERCURY™ – Big Data Tools for Exploration of Large-Scale Genomic Data
IntegraGen today announced the launch of SIRIUS™ and MERCURY™, two separate Big Data SaaS tools which enable the extensive exploration of large scale genomic data to assist in the diagnosis and management of patients.
09 January 2018
Register now – 9èmes Assises de Génétique, IntegraGen Genomics Lunch Workshop
29 June 2016
AP-HP and IntegraGen agree to develop a common platform for high-throughput sequencing
The Greater Paris University Hospitals (AP-HP) and IntegraGen announced today an agreement to develop a high-throughput sequencing platform (exome and whole genome) to be utilized for research projects and clinical research initiatives. This three-year research partnership aligns with a major objective of AH-HP’s 2015-2019 Strategic Plan related to (…) »
16 November 2015
Gustave Roussy and IntegraGen announce completion of 1,000 analyses with clinical research sequencing platform
Gustave Roussy and IntegraGen announced the achievement of one thousand genomic analyses utilizing their combined sequencing platform. The molecular profiles of cancer patients were analyzed as part of personalized medicine clinical trials being conducted at Gustave Roussy. The ability to deliver these results in less than three weeks (…) »
25 August 2015
Results from sequencing of 193 liver tumors performed by IntegraGen identifies potential role of a new virus in the development of liver cancer
IntegraGen announces a publication in Nature Genetics reporting the role of adeno-associated virus type 2 (AAV2) virus in the development of liver cancer. Professor Jessica Zucman-Rossi and her colleagues at Inserm Unit 1162 in Paris, supported by expert sequencing services from IntegraGen, identified the role of AAV2, a (…) »
08 July 2015
AP-HP : Georges Pompidou European Hospital and IntegraGen announce a cooperation agreement for access to a high-throughput sequencing platform
IntegraGen and the Georges Pompidou European Hospital (HEGP) announce the signing of an agreement to develop the use of high-throughput sequencing techniques to improve the care of patients viagra moins cher.
05 May 2015
Introducing IntegraNews – Read about the latest news from IntegraGen Genomics
Welcome to the inaugural issue of our newsletter. The goal of IntegraNews is to provide an update on the latest news and events at IntegraGen Genomics. This includes the availability of the latest technologies and molecular testing platforms in our lab and new service offerings.
